Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    June 2021
  1. AWAD MM, Liu S, Rybkin II, Arbour KC, et al
    Acquired Resistance to KRAS(G12C) Inhibition in Cancer.
    N Engl J Med. 2021;384:2382-2393.
    PubMed     Abstract available


    March 2021
  2. ROUSSEAU B, Foote MB, Maron SB, Diplas BH, et al
    The Spectrum of Benefit from Checkpoint Blockade in Hypermutated Tumors.
    N Engl J Med. 2021;384:1168-1170.
    PubMed    


  3. DIAZ LA JR, Le DT, Andre T
    Microsatellite-Instability-High Advanced Colorectal Cancer. Reply.
    N Engl J Med. 2021;384:972-973.
    PubMed    


  4. SORSCHER S
    Microsatellite-Instability-High Advanced Colorectal Cancer.
    N Engl J Med. 2021;384:972.
    PubMed    


  5. BATTISTUZZI L, Puccini A, Sciallero S
    Microsatellite-Instability-High Advanced Colorectal Cancer.
    N Engl J Med. 2021;384:971-972.
    PubMed    


    December 2020
  6. GROTHEY A
    Pembrolizumab in MSI-H-dMMR Advanced Colorectal Cancer - A New Standard of Care.
    N Engl J Med. 2020;383:2283-2285.
    PubMed    


  7. ANDRE T, Shiu KK, Kim TW, Jensen BV, et al
    Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
    N Engl J Med. 2020;383:2207-2218.
    PubMed     Abstract available


    November 2020
  8. LU KH, Broaddus RR
    Endometrial Cancer.
    N Engl J Med. 2020;383:2053-2064.
    PubMed    


    September 2020
  9. HONG DS, Fakih MG, Strickler JH, Desai J, et al
    KRAS(G12C) Inhibition with Sotorasib in Advanced Solid Tumors.
    N Engl J Med. 2020;383:1207-1217.
    PubMed     Abstract available


  10. BURKE CA, Dekker E, Lynch P, Samadder NJ, et al
    Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis.
    N Engl J Med. 2020;383:1028-1039.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: